Company / EPS (Diluted)
Xenetic Biosciences, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.57
FY2025
5-year range
-$4.61 / -$0.55
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-9.66 in FY2019 to $-0.41 in FY2018.
Based on SEC 10-K filings.
-2.57 in FY2025.
Improved from $-4.61 to $-2.57 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 5.2% year-over-year.
- Peak eps (diluted) was recorded in FY2018.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.57 | +5.2% |
| FY2024 | -$2.71 | +41.2% |
| FY2023 | -$4.61 | -738.2% |
| FY2022 | -$0.55 | +67.6% |
| FY2021 | -$1.70 | +73.1% |
| FY2020 | -$6.33 | +34.5% |
| FY2019 | -$9.66 | -2256.1% |
| FY2018 | -$0.41 | +94.8% |
| FY2017 | -$7.84 | -164.9% |
| FY2016 | -$2.96 | -4128.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026